IDBI Healthcare Fund Direct Growth

Very High Risk
Equity
Sector - Healthcare

NAV as on Apr 30, 2026

Price per unit of the scheme.

₹ 32.35620.07%1 Day Change

7.45%

Minimum Investment₹5000

Expense Ratio1.24%

FUND RATING

A holistic measure of the rank of a fund relative to its peers. Top funds receive a score of 5.

*Morningstar Rating Methodology i

RISK-O-METER

Level of risk associated with a mutual fund to help investors make informed investment decisions

FUND PERFORMANCE

As On Jan 01, 2023

Compare fund’s performance against category average across different time periods

No Data Found.

Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

For calculating Category Return & Scheme Ranking, only Growth & Direct schemes are considered.

FUND COMPARISON

1M 3M 6M 1Y 3Y 5Y

This Fund

IDBI Healthcare Fund Direct Growth

Equity: Sector - Healthcare Average NAV

Topper in Equity: Sector - Healthcare

All Fund

No Data Found.

*For the other fund, rescaled NAVs are used

RETURN CALCULATOR

Check the return on your investment in the fund

IDBI Healthcare Fund Direct Growth

Investment Type

Monthly Investment

Time Period (yrs)

Annual Return in %

Invested Amount
₹0
Return
₹0

Current Value
₹0

FUND SUMMARY

Benchmark

S&P BSE Healthcare TR INR

Expense Ratio

1.24%

Category Avg Expense Ratio

1.01%

Minimum Investment (Lumpsum/SIP)

₹ 5000 /₹ 1000

Lock In (Years)

No Lock-in

Fund Size

₹ 78.30 Cr(As on Mar, 2026)

Inception Date

Feb 28, 2019

Turnover

- %

Exit Load

Nil, If units of the Scheme areredeemed or switched out up to12% of the units (the limit) within 90days from the date of allotment.1% of the applicable NAV, If units ofthe scheme are redeemed orswitched out in excess of the limitwithin 90 days from the date ofallotment.Nil, If units of scheme are redeemedor switched out after 90 days fromthe date of allotment.

ABOUT THE FUND

Objective: The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.

IDBI Healthcare Fund Direct Growth is an Equity - Sector - Healthcare fund. The fund was launched inFeb 28, 2019. Its risk level is . The NAV of the fund as onApr 30, 2026 is ₹32.36. Its expense ratio is 1.24 %. The fund has an AUM of ₹78.30 Cr.The fund is managed byAlok Ranjan,Karan Doshi,Sudhanshu Asthana.
The minimum initial investment is ₹5000 in Lumpsum mode.

SUBSCRIBE TO

BUSINESS TODAY MAGAZINE

Subscribe Now

Already a subscriber?Login

FUND MANAGER

Alok Ranjan

Lead Fund Manager.

Aug 6, 2021 - Present

Fund Manager Rank6Out of 10
i
Rank measured on the basis of consistent alpha the fund manager delivered in the same category over a period of three years (factors only Direct plan, Growth option)
Schemes managed11
Total AUM₹ 2,774.36 Cr
Highest Return In 1 Yr18.07 %

Other Funds

table
card

Fund NameMorningstar RatingNAVFund ReturnCategory ReturnRiskFund Size

IDBI Focused 30 Equity Fund Direct Growth

₹ 21.97

7.64%

10.17%

Very High Risk

₹146.09Cr

IDBI Equity Savings Growth Option Direct

₹ 31.78

4.83%

3.04%

Moderately High risk

₹32.22Cr

IDBI Midcap Fund Direct Growth

₹ 32.32

14.33%

12.65%

Very High Risk

₹300.89Cr

IDBI Focused 30 Equity Fund Direct Growth

Very High Risk

NAV₹ 21.97
Fund Size₹146.09Cr

Fund Return7.64%

Category Return10.17%

IDBI Equity Savings Growth Option Direct

Moderately High risk

NAV₹ 31.78
Fund Size₹32.22Cr

Fund Return4.83%

Category Return3.04%

IDBI Midcap Fund Direct Growth

Very High Risk

NAV₹ 32.32
Fund Size₹300.89Cr

Fund Return14.33%

Category Return12.65%

Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

Karan Doshi

Lead Fund Manager.

Jul 31, 2023 - Present

Fund Manager Rank6Out of 10
i
Rank measured on the basis of consistent alpha the fund manager delivered in the same category over a period of three years (factors only Direct plan, Growth option)
Schemes managed10
Total AUM₹ 3,882.18 Cr
Highest Return In 1 Yr18.07 %

Other Funds

table
card

Fund NameMorningstar RatingNAVFund ReturnCategory ReturnRiskFund Size

LIC MF Equity Hybrid Fund Direct Plan Growth Option

₹ 219.96

8.37%

7.35%

Very High Risk

₹470.35Cr

LIC MF Childrens Gift Fund Direct Plan

₹ 35.54

10.24%

Very High Risk

₹13.59Cr

LIC MF Debt Hybrid Fund Direct Plan Growth Option

₹ 91.86

1.41%

2.18%

Moderately High risk

₹45.59Cr

LIC MF Equity Hybrid Fund Direct Plan Growth Option

Very High Risk

NAV₹ 219.96
Fund Size₹470.35Cr

Fund Return8.37%

Category Return7.35%

LIC MF Childrens Gift Fund Direct Plan

Very High Risk

NAV₹ 35.54
Fund Size₹13.59Cr

Fund Return10.24%

Category Return--

LIC MF Debt Hybrid Fund Direct Plan Growth Option

Moderately High risk

NAV₹ 91.86
Fund Size₹45.59Cr

Fund Return1.41%

Category Return2.18%

Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

Sudhanshu Asthana

Lead Fund Manager.

Apr 7, 2026 - Present

Fund Manager Rank6Out of 10
i
Rank measured on the basis of consistent alpha the fund manager delivered in the same category over a period of three years (factors only Direct plan, Growth option)
Schemes managed5
Total AUM₹ 4,575.25 Cr
Highest Return In 1 Yr8.62 %

Other Funds

table
card

Fund NameMorningstar RatingNAVFund ReturnCategory ReturnRiskFund Size

LIC MF Large & Mid Cap Direct Growth

₹ 42.92

8.97%

10.70%

Very High Risk

₹2,709.75Cr

IDBI Healthcare Fund Direct Growth

₹ 32.36

7.45%

6.49%

Very High Risk

₹78.30Cr

LIC MF Balanced Advantage Fund Direct Growth

₹ 14.20

5.28%

5.59%

Very High Risk

₹652.81Cr

LIC MF Large & Mid Cap Direct Growth

Very High Risk

NAV₹ 42.92
Fund Size₹2,709.75Cr

Fund Return8.97%

Category Return10.70%

IDBI Healthcare Fund Direct Growth

Very High Risk--

NAV₹ 32.36
Fund Size₹78.30Cr

Fund Return7.45%

Category Return6.49%

LIC MF Balanced Advantage Fund Direct Growth

Very High Risk--

NAV₹ 14.20
Fund Size₹652.81Cr

Fund Return5.28%

Category Return5.59%

Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

DETAILED PORTFOLIO

As on Mar, 2026

EQUITY (96.18%)

DEBT (-%)

CASH (3.82%)

Allocation by Market Cap

Large Cap(35.48%)

Mid Cap(28.99%)

Small Cap(31.70%)

Industry Holdings

Drug Manufacturers Specialty Generic60.52%
Medical Care18.26%
Biotechnology9.32%
Specialty Chemicals3.68%
Chemicals3.37%
Diagnostics Research2.73%

Stock Holdings

Sun Pharmaceuticals Industries Ltd11.77%
Torrent Pharmaceuticals Ltd7.08%
Apollo Hospitals Enterprise Ltd6.84%
Aurobindo Pharma Ltd5.21%
Divi's Laboratories Ltd4.68%
Fortis Healthcare Ltd4.37%

PERFORMANCE MEASURES

Fund evaluation across critical parameters for better decision making. Study period is 3 years.

Consistency
i
It represents the consistency of a fund in beating its benchmark.
Downside Risk
i
Measured by Maximum Drawdown which shows the maximum loss from a peak to a nadir over a specified time period
Risk Adjusted Return
i
Risk adjusted return represents the return generated after factoring the risk taken to achieve it.
Volatility
i
Volatility represents the standard deviation of fund returns that is, how much the fund returns have deviated from the average.
Upside Capture Ratio
i
Fund performance relative to the index when the market is up. An upside capture ratio of >100 indicates better fund performance.
Downside Capture Ratio
i
Fund performance relative to the index when the market is down. A downside capture ratio of <100 indicates better fund performance.

HISTORICAL RISK MEASURES

Statistical measures to evaluate mutual fund risk. All ratios are calculated for a three-year time duration.

Alpha: Excess return of the fund over benchmark
i
Any Alpha above zero is considered good. However, for comparison, a fund with a higher Alpha is considered better. Alpha is normally used in conjunction with Beta. If the Beta is high, it implies that the fund manager took a high risk to generate Alpha.
-0.66
This Fund
VS
-0.19
Category Avg
R-Squared: How well the fund tracks benchmark
i
R-Squared measures the correlation of fund returns and its benchmark returns. It varies between 0 and 1. The metric, Beta makes no sense if R-Squared is equal to zero. Thus, both Beta and R-Squared should be used in conjunction. A fund with a high R-Squared and low Beta is considered a less risky fund.
93.19
This Fund
VS
94.50
Category Avg

Beta: Risk of the fund in relation to benchmark
i
Beta >1 indicates that the fund is more volatile than its benchmark while Beta < 1 indicates that the fund is less volatile than its benchmark. The Beta of the benchmark is equal to 1.
0.93
This Fund
VS
0.95
Category Avg
Sharpe Ratio: Risk adjusted return of the fund
i
Sharpe Ratio is a measure of return per unit of risk. A higher Sharpe ratio indicates better risk adjusted return given by the fund.
0.95
This Fund
VS
0.96
Category Avg

Sortino Ratio: Return per unit of bad risk
i
A variation of Sharpe ratio, Sortino considers only the downside risk. Unlike Sharpe ratio which considers both good risk and bad risk, Sortino factors only the bad risk. A high Sortino ratio indicates better return for each unit of downside risk.
1.69
This Fund
VS
1.70
Category Avg
Standard Devation: Volatility of the fund
i
Standard deviation is a measure of dispersion of fund returns from its average return. A fund with a higher Standard deviation is more volatile than a fund with a low standard deviation.
16.30
This Fund
VS
16.46
Category Avg

Benchmark used in calculation : S&P BSE 500 India TR INR

PEER ANALYSIS

card
table

Fund NameMorningstar RatingNAV Fund Return Category ReturnRisk Fund Size

Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

TOP FUNDS FROM THIS AMC

card
table

Fund NameMorningstar RatingNAV Fund Return Category Return Risk Fund Size (Cr)

Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

ABOUT THE AMC

LIC Mutual Fund Asset Management Limited

LIC Mutual Fund Asset Management Limited manages assets worth ₹ 38,635.77 crores. It’s current offering of mutual fund schemes includes 12 equity, 7 debt and 6 hybrid schemes.

Phone

+91 022-66016000

cs.co@licmf.com

AUM

₹ 38,635.77 Cr (

As on Mar 31, 2026

)

Address

4th Floor, Industrial Assurance Building, Mumbai,400 020

FAQs

What is the category of IDBI Healthcare Fund Direct Growth ?

The category of IDBI Healthcare Fund Direct Growth is Equity - Sector - Healthcare

What is the current NAV of IDBI Healthcare Fund Direct Growth ?

The current NAV of IDBI Healthcare Fund Direct Growth as on Apr 30, 2026 is ₹32.36

How safe is IDBI Healthcare Fund Direct Growth ?

The risk level of IDBI Healthcare Fund Direct Growth is Very High.

What are short term returns given by IDBI Healthcare Fund Direct Growth ?

The return given by IDBI Healthcare Fund Direct Growth in 1 month is 7.45%, 3 months is 7.53%, 6 months is -0.99%, and 1 year is 6.05%

What are the long term returns given by IDBI Healthcare Fund Direct Growth ?

The return given by IDBI Healthcare Fund Direct Growth in 3 years is 22.53% and 5 years is 11.96%.

What is the expense ratio of IDBI Healthcare Fund Direct Growth ?

The expense ratio of IDBI Healthcare Fund Direct Growth is 1.24%

What is the AUM of IDBI Healthcare Fund Direct Growth ?

The assets under Management (AUM) of IDBI Healthcare Fund Direct Growth is Rs 78.30 crores.

What is the minimum investment in IDBI Healthcare Fund Direct Growth ?

The minimum Lumpsum investment in IDBI Healthcare Fund Direct Growth is ₹5,000.00 and the minimum SIP investment in IDBI Healthcare Fund Direct Growth is ₹1,000.00

What is the asset allocation of IDBI Healthcare Fund Direct Growth?

IDBI Healthcare Fund Direct Growth has an exposure of 96.18% in Equity and 3.82% in Cash & Money Market Securities